Product information CaReS® basic technology

The CaReS® basic technology is an innovative technology for the treatment of joint lesions. The patented 3D cell-collagen type I matrix provides a high cell activity and functionality and an almost natural production of cartilage-specific collagen type II.

The collagen type I matrix was developed in collaboration with the Fraunhofer Institute for Interfacial Engineering and Biotechnology (IGB, Institut für Grenzflächen- und Bioverfahrenstechnik) in Stuttgart, Germany. Unlike the carrier media in the collagen foam or resorbable fleece the chondrocytes can be clearly defined and controlled in the collagen. Moreover, only a small quantity of chondrocytes is needed for a gel matrix based cell transplantation. During surgery, height and shape of the CaReS® implant can be adapted to the defect.


  • Clearly defined cell matrix constructs
  • Due to 0-passages production times are reduced considerably
  • Chondrocytes in the CaReS® matrix have a high cell vitality
  • CaReS® grafts provide an excellent bonding to the surrounding cartilage.
  • Mini-arthrotomy makes surgery simple and fast
  • The surrounding structures are not damaged by sutures or pins.
  • The osmotic properties of CaReS® ensure optimal nourishment of the chondrocytes.
  • The CaReS® basic technology is manufactured in accordance with the principles of Good Manufacturing Practice (GMP).


The CaReS® basic technology is available as technology transfer throughout the world!